Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Molecular Cancer Therapeutics|October 1, 2009
Pharmacokinetics-pharmacodynamics and antitumor activity of mercaptoacetamide-based histone deacetylase inhibitorsZacharoula Konsoula, Hong Cao, Alfredo Velena, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 2011
Adamantanyl-histone deacetylase inhibitor H6CAHA exhibits favorable pharmacokinetics and augments prostate cancer radiation sensitivityZacharoula Konsoula, Hong Cao, Alfredo Velena, et al.
Frontiers in Oncology|December 29, 2025
Proton-boron capture interaction enhances killing of radiation resistant cancer cellsDalong Pang, Mira Jung, Alfredo Velena, et al.
Advances in Experimental Medicine and Biology|September 9, 2011
Histone deacetylase inhibitor: antineoplastic agent and radiation modulatorZacharoula Konsoula, Alfredo Velena, Rachel Lee, et al.
The Journal of Biological Chemistry|April 27, 2002
HPV-16 E6/7 immortalization sensitizes human keratinocytes to ultraviolet B by altering the pathway from caspase-8 to caspase-9-dependent apoptosisCynthia M Simbulan-Rosenthal, Alfredo Velena, Timothy Veldman, et al.
Advances in Experimental Medicine and Biology|October 3, 2019
African-American Prostate Normal and Cancer Cells for Health Disparities ResearchNicole Nicolas, Geeta Upadhyay, Alfredo Velena, et al.
Radiation Research|April 27, 2005
Novel HDAC inhibitors with radiosensitizing propertiesMira Jung, Alfredo Velena, Bin Chen, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2005
Chemistry and biology of mercaptoacetamides as novel histone deacetylase inhibitorsBin Chen, Pavel A Petukhov, Mira Jung, et al.
The Journal of Biological Chemistry|December 17, 2002
Expression of dominant-negative Fas-associated death domain blocks human keratinocyte apoptosis and vesication induced by sulfur mustardDean S Rosenthal, Alfredo Velena, Feng-Pai Chou, et al.
Bioorganic & Medicinal Chemistry|December 7, 2007
Phenylalanine-containing hydroxamic acids as selective inhibitors of class IIb histone deacetylases (HDACs)Stefan Schäfer, Laura Saunders, Elena Eliseeva, et al.
Pageof 2